Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M961Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M961EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with PBE

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PBE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PBE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Gold, Marc E.Director or Senior Officer of Insider or Subsidiar 2015-03-26Sell1,420$40.3634.76view
Monty, Jean ClaudeDirector, Director or Senior Officer of 10% Securi 2015-03-26Sell83,333$13.85292.71view
Monty, Jean ClaudeDirector, Director or Senior Officer of 10% Securi 2015-03-26Sell100,000$13.7297.01view
Kelly, Maureen AnnSenior Officer 2015-03-26Buy14,000$15.85243.15view
Owen, LoudonDirector 2015-03-26Buy6,000$0.4811231.25view
Owen, LoudonDirector 2015-03-26Buy9,000$0.4911000view
Owen, LoudonDirector 2015-03-26Buy35,000$0.4911000view
Whittle, David EdwardDirector 2015-03-26Buy2,000$3.31548.18view
Howald, William CarlDirector, Senior Officer 2015-03-26Buy10,000$0.1536160view
Saunders, Raymond JamesDirector 2015-03-26Buy215,000$0.04135875view

Press Releases about PBE :

    Quarterly/Annual Reports about PBE:

      News about PBE:

      Articles On GuruFocus.com

      More From Other Websites
      3 Biotech ETFs in Focus as Biogen Soars - ETF News And Commentary Mar 23 2015
      ETFs for the Next Biotech Takeover Targets Mar 10 2015
      POWERSHARES EXCHANGE TRADED FUND TRUST Financials Mar 06 2015
      Biotech ETFs Sholud Like AbbVie’s bid for Pharmacyclics Mar 05 2015
      Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary Feb 06 2015
      ‘Tis the Season for Biotech ETFs Jan 05 2015
      3 Biotech ETFs Rally On Merger News Dec 08 2014
      The Dominance of Health Care ETFs in One Chart Nov 20 2014
      Biotech ETFs Prescribe New ETFs Oct 23 2014
      Biotech ETFs Aren’t Waving the White Flag…Yet Oct 15 2014
      The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First... Oct 03 2014
      The Complete Guide to Biotech ETFs Sep 30 2014
      Five Forces that Will Shape the 21st Century Sep 29 2014
      Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? Sep 09 2014
      Interesting Biotech ETF Additions on the Way Sep 05 2014
      Biotech ETFs Look to Build on Hot August Returns Sep 03 2014
      Biotechnology ETFs Show Robust Health In August Sep 02 2014
      Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) Aug 27 2014
      After Recent Surge, Are Biotech ETFs Back on Track? Aug 26 2014
      Biotech ETFs Surge on InterMune-Roche Deal Aug 26 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK